I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hege, Kristen
53
results:
Search for persons
X
Format
Online (53)
Mediatypes
Articles (Online) (26)
OpenAccess-fulltext (27)
Sorted by: Relevance
Sorted by: Year
?
1
Idecabtagene vicleucel for relapsed and refractory multiple..:
Lin, Yi
;
Raje, Noopur S.
;
Berdeja, Jesús G.
...
Nature Medicine. 29 (2023) 9 - p. 2286-2294 , 2023
Link:
https://doi.org/10.1038/..
?
2
Characterizing the exposure–response relationship of idecab..:
Connarn, Jamie N.
;
Witjes, Han
;
van Zutphen‐van Geffen, Marielle
...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 11 - p. 1687-1697 , 2023
Link:
https://doi.org/10.1002/..
?
3
S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR C..:
Bal, Susan
;
Berdeja, Jesus
;
Htut, Myo
...
HemaSphere. 7 (2023) S3 - p. e9863287 , 2023
Link:
https://doi.org/10.1097/..
?
4
Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in ..:
Zeidan, Amer M.
;
DeAngelo, Daniel J.
;
Palmer, Jeanne
...
Annals of Hematology. 101 (2022) 3 - p. 557-569 , 2022
Link:
https://doi.org/10.1007/..
?
5
Phase Ib study of combinations of avadomide (CC‐122), CC‐22..:
Ribrag, Vincent
;
Chavez, Julio C.
;
Boccomini, Carola
...
eJHaem. 3 (2022) 1 - p. 139-153 , 2022
Link:
https://doi.org/10.1002/..
?
6
Patient experience before and after treatment with idecabta..:
Shah, Nina
;
Delforge, Michel
;
San-Miguel, Jesus
...
Leukemia Research. 120 (2022) - p. 106921 , 2022
Link:
https://doi.org/10.1016/..
?
7
Matching adjusted indirect comparisons of efficacy outcomes..:
Rodriguez-Otero, Paula
;
Ayers, Dieter
;
Cope, Shannon
...
Leukemia & Lymphoma. 62 (2021) 10 - p. 2482-2491 , 2021
Link:
https://doi.org/10.1080/..
?
8
Context matters in CAR T cell tonic signaling:
Hege, Kristen
Nature Medicine. 27 (2021) 5 - p. 763-764 , 2021
Link:
https://doi.org/10.1038/..
?
9
Biallelic loss of BCMA as a resistance mechanism to CAR T c..:
Samur, Mehmet Kemal
;
Fulciniti, Mariateresa
;
Aktas Samur, Anil
...
Nature Communications. 12 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
10
OAB-027: Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-d..:
Jr, Larry D. Anderson,
;
Shah, Nina
;
Jagannath, Sundar
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S17-S18 , 2021
Link:
https://doi.org/10.1016/..
?
11
Homozygous BCMA gene deletion in response to anti-BCMA CAR ..:
Da Vià, Matteo C.
;
Dietrich, Oliver
;
Truger, Marietta
...
Nature Medicine. 27 (2021) 4 - p. 616-619 , 2021
Link:
https://doi.org/10.1038/..
?
12
CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How ..:
Kim, Gloria B.
;
Hege, Kristen
;
Riley, James L.
Frontiers in Immunology. 10 (2019) - p. , 2019
Link:
https://doi.org/10.3389/..
?
13
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (..:
Wolin, Edward
;
Mita, Alain
;
Mahipal, Amit
...
PLOS ONE. 14 (2019) 9 - p. e0221994 , 2019
Link:
https://doi.org/10.1371/..
?
14
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-..:
Munster, Pamela
;
Mita, Monica
;
Mahipal, Amit
...
Cancer Management and Research. 11 (2019) - p. 10463-10476 , 2019
Link:
https://doi.org/10.2147/..
?
15
A phase I dose‐escalation study to assess safety, tolerabil..:
Bendell, Johanna C.
;
Kelley, Robin K.
;
Shih, Kent C.
...
Cancer. 121 (2015) 19 - p. 3481-3490 , 2015
Link:
https://doi.org/10.1002/..
1-15